Lifeworks Advisors LLC Acquires New Shares in CVS Health Corporation $CVS

Lifeworks Advisors LLC bought a new stake in shares of CVS Health Corporation (NYSE:CVS) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 5,739 shares of the pharmacy operator’s stock, valued at approximately $412,000.

Several other hedge funds have also recently modified their holdings of the business. Hamlin Capital Management LLC purchased a new position in shares of CVS Health in the 4th quarter worth $160,844,000. Capitolis Liquid Global Markets LLC purchased a new stake in CVS Health during the third quarter valued at $11,308,000. National Bank of Canada FI lifted its holdings in CVS Health by 50.3% in the third quarter. National Bank of Canada FI now owns 1,770,840 shares of the pharmacy operator’s stock valued at $133,495,000 after acquiring an additional 593,015 shares during the period. State Street Corp lifted its holdings in CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after acquiring an additional 1,245,457 shares during the period. Finally, Fort Washington Investment Advisors Inc. OH boosted its position in CVS Health by 2.9% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 725,189 shares of the pharmacy operator’s stock worth $57,551,000 after purchasing an additional 20,217 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE:CVS opened at $105.97 on Tuesday. The company has a market capitalization of $135.21 billion, a P/E ratio of 46.68, a P/E/G ratio of 1.02 and a beta of 0.61. CVS Health Corporation has a 1-year low of $58.50 and a 1-year high of $106.40. The firm’s 50 day simple moving average is $97.36 and its two-hundred day simple moving average is $84.41. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The firm had revenue of $100.43 billion during the quarter, compared to analysts’ expectations of $94.99 billion. During the same period in the prior year, the company posted $2.25 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Research analysts expect that CVS Health Corporation will post 7.44 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.5%. CVS Health’s dividend payout ratio (DPR) is currently 117.18%.

Insider Activity

In related news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the transaction, the executive vice president directly owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. The trade was a 87.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Larry Robbins sold 1,983,538 shares of the stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $94.45, for a total transaction of $187,345,164.10. Following the sale, the director directly owned 6,213,261 shares of the company’s stock, valued at approximately $586,842,501.45. This trade represents a 24.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 3,441,551 shares of company stock worth $323,703,977 over the last 90 days. Company insiders own 0.85% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on CVS. Barclays upped their price target on shares of CVS Health from $101.00 to $106.00 and gave the company an “overweight” rating in a research report on Tuesday, May 26th. DA Davidson upped their target price on shares of CVS Health from $80.00 to $100.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Robert W. Baird increased their price target on shares of CVS Health from $92.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. Morgan Stanley lifted their price target on shares of CVS Health from $106.00 to $111.00 and gave the stock an “overweight” rating in a research note on Thursday, June 4th. Finally, HSBC reissued a “hold” rating and set a $103.00 price objective on shares of CVS Health in a research report on Monday, July 6th. Twenty-one equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $103.64.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.